MedTrace Logo

Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers

NCT04181008 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-03-08

No results posted yet for this study

Summary

This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.

Conditions

  • Pharmacokinetics

Interventions

DRUG

Amiloride

Amiloride Nasal Spray

DRUG

Amiloride

Amiloride Nasal Spray

DRUG

Amiloride

Amiloride Nasal Spray

Sponsors & Collaborators

  • Center for Addiction and Mental Health

    collaborator UNKNOWN

  • University of Utah

    lead OTHER

Principal Investigators

  • Venkata K Yellepeddi, PhD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-28
Primary Completion
2022-08-30
Completion
2023-03-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181008 on ClinicalTrials.gov